Clinical Trial Update: First Study of the Safety of CNTO 888 in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety study of CNTO 888 in patients with solid tumors. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• CNTO 888

Snippet

Sponsor: Centocor, Inc. | Conditions: Cancer | Phase 1 | Status: COMPLETED